Monivent ABXSAT:MONI +3.41%26 FCF Yield % is -33.42 as of Jun. 30, 2026. GuruFocus rates XSAT:MONI with a GF Score™ of 26/100 and a GF Value™ of kr0.05 (Significantly Overvalued). The stock has 8 warning signs investors should review. Among 854 Medical Devices & Instruments companies, Monivent AB ranks worse than 88.52% on this metric.
FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.
The historical rank and industry rank for Monivent AB's FCF Yield % or its related term are showing as below:
XSAT:MONI'
s FCF Yield % Range Over the Past 10 Years
Min: -364.58 Med: -40.43 Max: -11.8
Current: -33.42
During the past 9 years, the highest FCF Yield % of Monivent AB was -11.80%. The lowest was -364.58%. And the median was -40.43%.
XSAT:MONI's FCF Yield % is ranked worse than 88.52% of 854
companies
in the Medical Devices & Instruments industry
Industry Median: -0.385
vs XSAT:MONI: -33.42
Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.
Monivent AB FCF Yield % Related Terms
Monivent AB FCF Yield % Historical Data
* Premium members only.
The historical data trend for Monivent AB's FCF Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
XSAT:MONI vs ABT, SYK, MDT: FCF Yield % Comparison
For the Medical Devices subindustry, Monivent AB's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Monivent AB FCF Yield % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Monivent AB's FCF Yield % distribution charts can be found below:
* The bar in red indicates where Monivent AB's FCF Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Monivent AB (XSAT:MONI) has a FCF Yield % of -33.42 as of Jun. 30, 2026. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on Monivent AB and its competitors. According to the industry distribution chart, Monivent AB ranks #756 out of 854 companies in the Medical Devices & Instruments industry, placing it in the top 88.5%.
Is Monivent AB's FCF Yield % too high?
Monivent AB's current FCF Yield % is -33.42. Based on the distribution chart, Monivent AB ranks #756 out of 854 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Monivent AB has a GF Score™ of 26/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Monivent AB's FCF Yield % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Monivent AB ranks #756 out of 854 companies for FCF Yield %. This places Monivent AB in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Yield % for a Medical Devices & Instruments company?
A good FCF Yield % depends on the Medical Devices & Instruments industry context. However, FCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Yield % mean?
A high FCF Yield % can signal that a stock is expensive relative to its fundamentals. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on Monivent AB and its competitors. Monivent AB's current FCF Yield % is -33.42. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Monivent AB stock overvalued right now?
Based on GuruFocus' analysis, Monivent AB (XSAT:MONI) is currently considered Significantly Overvalued. The stock's GF Value™ is kr0.05, compared to a current price of kr0.42 — trading 748% above its estimated fair value. The current FCF Yield % is -33.42. Monivent AB's overall GF Score™ is 26/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Yield % calculated?
FCF Yield % is calculated from a company's financial statements. For Monivent AB (XSAT:MONI), the current FCF Yield % is -33.42 as of Jun. 30, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Monivent AB (XSAT:MONI) Overvalued in 2026?
Based on GuruFocus' analysis, Monivent AB stock appears to be overvalued.
The current stock price of kr0.42 is trading 748% above its estimated GF Value™ of kr0.05.
GuruFocus considers Monivent AB to be Significantly Overvalued.
Key valuation signals for XSAT:MONI:
FCF Yield %: -33.42
GF Value™: kr0.05 vs. price of kr0.42 (748% above fair value)
No single metric tells the full story. See the XSAT:MONI stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Monivent AB is a medtech company focused on improving the care given to newborn babies in need of respiratory support at birth. The company has developed a patented solution that provides continuous feedback on the volumes of air given to the newborn during manual ventilation. The airflow is measured directly in the face mask and feedback on the ventilation parameters is displayed numerically and graphically in real-time on the external monitor. The company's product is Monivent Neo100.
26GF Score
Get the complete analysis for XSAT:MONI
FCF Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XSAT:MONI has been successfully added to your 
